| Name | AYUMI Pharmaceutical Corporation |
|---|---|
| Date established | January 2015 |
| Capital | 100 million Japanese yen |
| Employees | 319(As of April 1, 2023) |
| Main business | Manufacture and sale of medical drugs, including rheumatism drugs and analgesic antipyretics |
| Representative director | President Hiroko Kusano |
| Principal shareholders | private equity funds managed by Blackstone (NYSE: BX) |
| Head office | Kabukiza Tower 19F 4-12-15 Ginza Chuo-ku, Tokyo 104-0061 JAPAN Tel: +81-3-6264-3540 |
▼ COMPANY INDEX
Copyright © AYUMI Pharmaceutical Corporation All Rights Reserved.
